174 related articles for article (PubMed ID: 33007298)
21. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
22. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
[TBL] [Abstract][Full Text] [Related]
23. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
Qiu X; Chen J; Zhang Z; You Y; Wang Z
Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic Control of the Vasopressin Promoter Explains Physiological Ability to Regulate Vasopressin Transcription in Dehydration and Salt Loading States in the Rat.
Greenwood MP; Greenwood M; Gillard BT; Loh SY; Paton JF; Murphy D
J Neuroendocrinol; 2016 Apr; 28(4):n/a. PubMed ID: 26833868
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
Kogashiwa Y; Inoue H; Kuba K; Araki R; Yasuda M; Nakahira M; Sugasawa M
Head Neck; 2018 Nov; 40(11):2424-2431. PubMed ID: 30302873
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
[TBL] [Abstract][Full Text] [Related]
30. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
Choudhury JH; Ghosh SK
PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
[TBL] [Abstract][Full Text] [Related]
31. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
32. Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.
Kim NY; Kim MC; Kim Y
Cancer Gene Ther; 2016 Dec; 23(12):425-432. PubMed ID: 27857059
[TBL] [Abstract][Full Text] [Related]
33. Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma.
Lan L; Cao H; Chi W; Meng W; Zhao L; Cui W; Wang B
Pathol Res Pract; 2020 Apr; 216(4):152877. PubMed ID: 32111441
[TBL] [Abstract][Full Text] [Related]
34. DNA hypermethylation of
Birknerová N; Kovaříková H; Baranová I; Přikrylová A; Laco J; Vošmiková H; Gajdošová B; Hodek M; Vošmik M; Palička V; Chmelařová M
Epigenetics; 2022 Nov; 17(11):1301-1310. PubMed ID: 34974810
[TBL] [Abstract][Full Text] [Related]
35. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
36. Importance of Tumour Suppressor Gene Methylation in Sinonasal Carcinomas.
Chmelařová M; Sirák I; Mžik M; Sieglová K; Vošmiková H; Dundr P; Němejcová K; Michálek J; Vošmik M; Palička V; Laco J
Folia Biol (Praha); 2016; 62(3):110-9. PubMed ID: 27516190
[TBL] [Abstract][Full Text] [Related]
37. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
38. Global epigenetic regulation of microRNAs in multiple myeloma.
Zhang W; Wang YE; Zhang Y; Leleu X; Reagan M; Zhang Y; Mishima Y; Glavey S; Manier S; Sacco A; Jiang B; Roccaro AM; Ghobrial IM
PLoS One; 2014; 9(10):e110973. PubMed ID: 25330074
[TBL] [Abstract][Full Text] [Related]
39. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
40. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Farooqui M; Bohrer LR; Brady NJ; Chuntova P; Kemp SE; Wardwell CT; Nelson AC; Schwertfeger KL
Mol Cancer; 2015 Jul; 14():138. PubMed ID: 26215578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
